← Back to Clinical Trials
RecruitingPhase 3NCT06570889
VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma
◆ AI Clinical Summary
Plain-language summary for patients
Trial Parameters
ConditionAsthma
SponsorProfessor Klaus Bønnelykke
Study TypeINTERVENTIONAL
PhasePhase 3
Enrollment2,000
SexFEMALE
Min Age18 Years
Max Age45 Years
Start Date2024-12-20
Completion2026-10
All Conditions
Interventions
Cholecalciferol D3Olive oil
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The overall aim of the study is to develop a nutritional preventive vitamin D supplementation strategy in pregnancy for early childhood asthma/persistent wheeze during the first three years of life as we hypothesize that supplementation in higher doses than recommended could reduce the risk of disease development.
Eligibility Criteria
* Pregnant Danish women before week 26 with blood levels of EPA+DHA above 4.7% of total fatty acids * No current vitamin D intake above the recommended 400 IU/day * No endocrine-, heart-, kidney- or auto-immune disorders * No disorders requiring treatment with blood thinning medication